Abstract 2342P
Background
Single tumor cells (STCs) are a manifestation of intratumor morphological heterogeneity and most likely arise from multicellular tumor structures as a result of cancer invasion. In recent years, the appearance of STCs has been described as tumor budding in the invasive front. However, there are no clear data on the clinical significance of these cells in breast cancer patients.
Methods
The study included 230 patients diagnosed with invasive breast carcinoma of the nonspecific type, luminal molecular subtypes. H&E staining was used to detect STCs in breast tissue. STCs (or detached individual tumor cells) were detected in the entire tumor tissue in contrast to tumor buds located in the invasive front, and were defined as tumor cells located outside multicellular tumor structures but similar to them in cytological features. 7-color immunofluorescence analysis was used to study the population composition of the microenvironment (ME) of STCs. Laser microdissection of STCs ME and sequencing on NextSeq500 (Illumina, USA) was performed.
Results
Patients who had a STCs had a 5.8-fold increased risk (CI95% 2.4-14.1) of developing distant metastases compared to patients who did not have a STCs (p=0.0001). Patients who had no STCs had a better metastatic-free survival (91.8%) than patients who had a STCs (49.1) (p<0.0001). The relative risk of distant metastases in breast cancer patients where only Th2-like immune reaction is found in the ME is 2.37 (CI95% 1.25-4.42) times higher than in patients where only Th1-like immune reaction (p=0.0352). In addition, a Top 10 analysis of up- and downregulated genes in the STCs ME in breast cancer patients depending on the status of distant metastasis was performed. Decrease of CD52 (7-fold), NUDT3 (6-fold), TAP1 (6-fold) (p<0.001) genes expression and increase of LAMA5 (4-fold), LPCAT1 (5-fold), FLVCR1 (5-fold) (p<0.001) genes expression were detected in the STCs ME of breast cancer patients with distant metastases compared to those without.
Conclusions
A novel simple prognostic criterion for predicting breast cancer metastasis has been developed. The microenvironment has been shown to play an important role in the metastatic potential of a single tumour cells. Immunosignatures of the pro-tumour microenvironment have been identified.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Tomsk National Research Medical Center.
Funding
The study was supported by the Russian Science Foundation (grant #23-15-00135).
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2335P - Spatial whole exome sequencing reveals the genetic features of highly-aggressive components in lung adenocarcinoma
Presenter: Jianfu Li
Session: Poster session 16
2336P - MiR-155 overexpression regulates epithelial-mesenchymal transition through repressing Quaking in lung cancer cells
Presenter: Jung-Jyh Hung
Session: Poster session 16
2337P - Feasibility of mutation detection in cytological samples from metastasis in patients with metastatic prostate cancer
Presenter: Marina Mencinger
Session: Poster session 16
2338P - The phenotype of tumor-associated macrophages in human high-grade serous ovarian carcinoma
Presenter: Irina Larionova
Session: Poster session 16
2339P - Clinical and genomic correlates of plasma circulating tumor DNA (ctDNA) tumor fraction (TF) in patients with advanced NSCLC
Presenter: Filippo Dall'Olio
Session: Poster session 16
2340P - T-cell immunoglobulin and mucin-domain containing molecule-3 (Tim3) in breast cancer and the impact on penetration of blood brain barrier by cancer cells
Presenter: Xiaoshan Cao
Session: Poster session 16
2341P - Novel therapeutic opportunities in metaplastic breast cancer
Presenter: Fresia Pareja
Session: Poster session 16
2343P - Evolution of circulating tumour DNA analysis in France over 5 years
Presenter: Guillaume Herbreteau
Session: Poster session 16
2345P - The possibility of programmed death-ligand 1-related immune modulation in neoadjuvant thermoradiotherapy for rectal cancer
Presenter: seihwan you
Session: Poster session 16
2346P - Spatial and quantified molecular characterization of high endothelial venule predictive of immunotherapy response
Presenter: Kunheng Du
Session: Poster session 16